Senti Biosciences Holdings, Inc
Price
FilingsNewest: 424B3, ProspectusSep 24 →InsidersNo open-market buys or sales.→HoldersNantahala 2.9%Vanguard 1.7%Geode 0.6%→Financing →PeersClosest companies: JSPR, RNAZ, CNSP→
From the filings
Figures
- Revenue
- $38,000last 12 months
- Net income
- −$49.6Mlast 12 months
- Operating cash flow
- −$36.9Mlast 12 months
- Cash and equivalents
- $6.5Mat the last balance sheet
- Shares outstanding
- 31.1M shareson issue